β¨ Medicines Act Notices
788
NEW ZEALAND GAZETTE
No. 30
Health
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Invirase
Active Ingredient: Saquinavir mesylate 228.7mg equivalent to 200mg Saquinavir free base
Dosage Form: Capsule
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: F Hoffmann-La Roche AG, Basel, Switzerland
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Note: This consent is valid for 2 years from 6 June 2002.
Dated this 22nd day of March 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2118
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Dysport
Active Ingredient: Clostridium botulinum type A toxin haemagglutinin complex 500U
Dosage Form: Powder for injection
New Zealand Sponsor: New Zealand Medical & Scientific Limited
Manufacturer: Ispen Limited, Wrexham Industrial Estate, Clwyd, United Kingdom
Dated this 22nd day of March 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2117
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: NeutraGard Plus (Tropical Blast flavour)
Active Ingredient: Sodium fluoride 0.2%w/v
Dosage Form: Topical solution
New Zealand Sponsor: Ivoclar Vivadent Limited
Manufacturer: Pascal Company Inc, Bellevue, Washington, United States of America
Product: NeutraGard Plus (Mint flavour)
Active Ingredient: Sodium fluoride 0.2%w/v
Dosage Form: Topical solution
New Zealand Sponsor: Ivoclar Vivadent Limited
Manufacturer: Pascal Company Inc, Bellevue, Washington, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 30
Gazette.govt.nz —
NZ Gazette 2002, No 30
β¨ LLM interpretation of page content
π₯ Renewal of Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare22 March 2002
Medicines, Provisional Consent, Invirase, Saquinavir mesylate, Roche Products
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social Welfare22 March 2002
Medicines, Consent, Dysport, Clostridium botulinum toxin, New Zealand Medical & Scientific Limited
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare22 March 2002
Medicines, Consent, NeutraGard Plus, Sodium fluoride, Ivoclar Vivadent Limited
- G. R. Boyd, Chief Advisor, Safety and Regulation